Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

September 30, 2009

Conditions
Anemia
Interventions
DRUG

epoetin beta

Subcutaneous administration of epoetin beta 36,000 IU once-weekly for 12 weeks

DRUG

placebo

Subcutaneous administration of placebo once-weekly for 12 weeks

Trial Locations (6)

Unknown

Chugoku/Shikoku Region, Chugoku/Shikoku

Chubu Region, Chūbu

Hokkaido/Tohoku Region, Hokkaido/Tohoku

Kanto/Koshinetsu Region, Kanto/Koshinetsu

Kinki/Hokuriku Region, Kinki/Hokuriku

Kyushu Region, Kyushu

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY